| 发明名称 |
Cxcr4 antagonist treatment of hematopoietic cells |
| 摘要 |
In accordance with various aspects of the invention, CXCR4 antagonists may be used to treat hematopoietic cells, such as progenitor or stem cells, to promote the rate of cellular multiplication, self-renewal, proliferation or expansion. CXCR4 antagonists may be used therapeutically to stimulate hematopoietic stem/progenitor cell multiplication/self-renewal. |
| 申请公布号 |
AU5811001(A) |
申请公布日期 |
2001.11.20 |
| 申请号 |
AU20010058110 |
申请日期 |
2001.05.09 |
| 申请人 |
THE UNIVERSITY OF BRITISH COLUMBIA;CHEMOKINE THERAPEUTICS CORPORATION |
发明人 |
CHRISTOPHER R. TUDAN;AHMED MERZOUK;LAKHDAR ARAB;GEETA SAXENA;CONNIE J. EAVES;JOHANNE CASHMAN;IAN CLARK-LEWIS;HASSAN SALARI |
| 分类号 |
A61K38/00;A61K38/10;A61K38/17;A61K45/00;A61K48/00;A61P35/00;A61P37/00;A61P37/06;A61P43/00;C07K7/06;C07K7/08;C07K14/00;C07K14/47;C07K14/52;C12N5/0789 |
主分类号 |
A61K38/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
